NCT03974633

Brief Summary

Injections are associated to a certain level of pain which tolerance can vary between individuals. As regards non-invasive pain control techniques in subcutaneous injections, scarce literature exists with adequate levels of evidence and design quality to support any specific analgesic method. In this study, the investigators evaluated the effectivity of three non-invasive analgesic techniques (cold, anesthetic cream and vibration) when performing subcutaneous forehead injections, in a series of 100 healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2019

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
Last Updated

August 22, 2019

Status Verified

August 1, 2019

Enrollment Period

1.2 years

First QC Date

May 28, 2019

Last Update Submit

August 19, 2019

Conditions

Keywords

AnalgesiaCryoanalgesiaVibration analgesiaLocal anesthetic

Outcome Measures

Primary Outcomes (1)

  • Pain referred per each zone injected: VAS

    Pain measured through a Visual Analogic Scale with values from 0 to 10; being 0 complete absence of pain, and 10 the worst pain ever experienced.

    1 hour max

Secondary Outcomes (2)

  • Discomfort associated to non-invasive analgesic techniques

    1 hour max

  • Preference of non-invasive analgesic technique

    1 hour max

Study Arms (4)

Control

PLACEBO COMPARATOR

A subcutaneous injection of 0,1mL saline (0,9%NaCl) was administered in a part of the forehead, without administering any type of non-invasive analgesic

Combination Product: Injection

Vibration

EXPERIMENTAL

A subcutaneous injection of 0,1mL saline (0,9%NaCl) was administered in a part of the forehead, while applicating a vibrating device on the skin below the injection site, before and during injection.

Combination Product: Injection

Cold

EXPERIMENTAL

A subcutaneous injection of 0,1mL saline (0,9%NaCl) was administered in a part of the forehead, after applicating a bag of 50mL of frozen physiologic saline covered with a plastic glove on the injection site for 50 seconds

Combination Product: Injection

Anesthetic cream

EXPERIMENTAL

subcutaneous injection of 0,1mL saline (0,9%NaCl) was administered in a part of the forehead, after applicating a uniform thickness of 2mm of the anesthetic cream EMLA covered with an adhesive transparent plastic dressing for 30 minutes

Combination Product: Injection

Interventions

InjectionCOMBINATION_PRODUCT

All information is included in the Arm/group descriptions

Anesthetic creamColdControlVibration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Subjects younger than 18
  • Subjects that suffered from any local or systemic sensitivity alteration
  • Subjects that suffered from any cognitive deficit
  • Individuals allergic to any of the components of the anesthetic ointment EMLA (eutectic mixture of lidocaine 2,5% and prilocaine 2,5%).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University and Polytechnic Hospital La Fe

Valencia, 46026, Spain

Location

Related Publications (7)

  • Babamiri K, Nassab R. The evidence for reducing the pain of administration of local anesthesia and cosmetic injectables. J Cosmet Dermatol. 2010 Sep;9(3):242-5. doi: 10.1111/j.1473-2165.2010.00503.x.

    PMID: 20883298BACKGROUND
  • Davoudi A, Rismanchian M, Akhavan A, Nosouhian S, Bajoghli F, Haghighat A, Arbabzadeh F, Samimi P, Fiez A, Shadmehr E, Tabari K, Jahadi S. A brief review on the efficacy of different possible and nonpharmacological techniques in eliminating discomfort of local anesthesia injection during dental procedures. Anesth Essays Res. 2016 Jan-Apr;10(1):13-6. doi: 10.4103/0259-1162.167846.

    PMID: 26957683BACKGROUND
  • Strazar AR, Leynes PG, Lalonde DH. Minimizing the pain of local anesthesia injection. Plast Reconstr Surg. 2013 Sep;132(3):675-684. doi: 10.1097/PRS.0b013e31829ad1e2.

    PMID: 23985640BACKGROUND
  • Taddio A, Lord A, Hogan ME, Kikuta A, Yiu A, Darra E, Bruinse B, Keogh T, Stephens D. A randomized controlled trial of analgesia during vaccination in adults. Vaccine. 2010 Jul 19;28(32):5365-9. doi: 10.1016/j.vaccine.2010.05.015. Epub 2010 May 16.

    PMID: 20483194BACKGROUND
  • Ernst E, Fialka V. Ice freezes pain? A review of the clinical effectiveness of analgesic cold therapy. J Pain Symptom Manage. 1994 Jan;9(1):56-9. doi: 10.1016/0885-3924(94)90150-3.

    PMID: 8169463BACKGROUND
  • Elibol O, Ozkan B, Hekimhan PK, Caglar Y. Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection. Ophthalmic Plast Reconstr Surg. 2007 Mar-Apr;23(2):130-3. doi: 10.1097/IOP.0b013e318030459c.

    PMID: 17413628BACKGROUND
  • Simons FE, Gillespie CA, Simons KJ. Local anaesthetic creams and intradermal skin tests. Lancet. 1992 May 30;339(8805):1351-2. doi: 10.1016/0140-6736(92)91994-j. No abstract available.

    PMID: 1350007BACKGROUND

MeSH Terms

Conditions

Agnosia

Interventions

Injections

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Drug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Enrique Salmeron-Gonzalez, MD

    University and Polytechnic Hospital La Fe

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes were studied by an investigator that did not participate in the practical part of the trial.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: All subjects received four injections of 0,1mL of physiologic saline (0,9%NaCl) in the forehead, 2cm above the eyebrows, with a 29G needle, after applying each one of the 4 non-invasive anesthetic methods studied in the trial, except for the control zone. The anesthetic method utilized in each part of the forehead of each patient was randomized through simple randomization.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 28, 2019

First Posted

June 5, 2019

Study Start

February 24, 2018

Primary Completion

April 22, 2019

Study Completion

May 1, 2019

Last Updated

August 22, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Individual Participant Data Set Access

Locations